Thank you for your submission. The information will be live within the next 24-48 hours.
AstraZeneca - ADDC Collaboration
The collaboration allows for ADDC members to have direct access to the AstraZeneca's library of compounds.
This collaboration between ADDC and AstraZeneca is aimed at at facilitating efforts by researchers from academia and institutions towards the discovery of novel compounds with potential pharmaceutical application.
Click here for more information
Highlighted Partnerships
IBD Therapeutics Incubator |
IBD Therapeutics Incubator: Request for ProposalsThe Crohn’s & Colitis Foundation (Foundation) is dedicated to addressing the unmet needs of patients with inflammatory bowel diseases (IBD). The... |
TB Drug Accelerator |
|
SDDC |
|
The DDU is now leading the SDDC. The Structure-guided Drug Discovery Coalition (SDDC) is an international research coalition led by the Structural Genomics Consortium, based at McGill University,... |
Research Collaboration and license agreement |
|
Beactica Therapeutics AB, the Swedish drug discovery company, and University of Dundee, a top-ranked university in the UK for biological sciences, today announced a new research collaboration... |
Research Collaboration and license agreement |
|
The Drug Discovery Unit announces a partnership with Takeda, Japan’s largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in... |
Therapeuitic Areas of Expertise
-
ChoicesPercentage
-
Oncology30.91%
-
Infectious Diseases18.18%
-
Neurological Disorders32.73%
-
Immunology23.64%
-
Metabolic Disorders20%
-
Cardiology12.73%
-
Pain7.27%
-
Other10.91%
-
Therapeutic Approaches
-
ChoicesPercentage
-
Small Molecules80%
-
Biologics38.18%
-
Biomarkers3.64%
-
Drug Delivery3.64%
-
Stem Cells3.64%
-
Vaccines1.82%
-
Antibodies9.09%
-
Other1.82%
-